Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-253.40%
60%
—
16.64%
60%
—
5 Years
Score4.0
Net Growth-253.40%
Net Trend60%
Net Income Consistency—
Rev Growth16.64%
Rev Trend60%
Revenue Consistency—
Rani Therapeutics Holdings Inc fundamental performance
Between 2021 and 2025, revenue declined from $ 2M to $ 1M and net income went from -$ 8M to -$ 29M. Revenue increased in 60% of the years measured; net income in 60%.
Rani Therapeutics Holdings Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.80 | — |
1 Year2025-08-12 | $ 0.53 | 51.19% |
5 Years2021-08-12 | $ 17.43 | -95.39% |
All Time2021-07-30 | $ 11.00 | -92.70% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-30 |
|---|---|---|---|---|
| Price | $ 0.80 | $ 0.53 | $ 17.43 | $ 11.00 |
| Return | — | 51.19% | -95.39% | -92.70% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3M | -$ 29M | $ 43M |
| 2025 | $ 1M | -$ 29M | $ 49M |
| 2024 | $ 1M | -$ 30M | $ 27M |
| 2023 | $ 0.00 | -$ 33M | $ 48M |
| 2022 | $ 0.00 | -$ 30M | $ 98M |
| IPO2021 | $ 2M | -$ 8M | $ 117M |
Explore beyond RANI
You're looking at Rani Therapeutics Holdings Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
